The store will not work correctly when cookies are disabled.
N'-((5-(pyridin-2-ylthio)furan-2-yl)methylene)isonicotinohydrazide
ID: ALA4476815
PubChem CID: 9563318
Max Phase: Preclinical
Molecular Formula: C16H12N4O2S
Molecular Weight: 324.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(N/N=C/c1ccc(Sc2ccccn2)o1)c1ccncc1
Standard InChI: InChI=1S/C16H12N4O2S/c21-16(12-6-9-17-10-7-12)20-19-11-13-4-5-15(22-13)23-14-3-1-2-8-18-14/h1-11H,(H,20,21)/b19-11+
Standard InChI Key: GFQRDSVVIODWDJ-YBFXNURJSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
14.2721 -19.1690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0893 -19.1690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3437 -18.3923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6807 -17.9102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0220 -18.3923 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6795 -17.0930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9712 -16.6855 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9699 -15.8683 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7910 -19.8295 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.1224 -20.5765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6394 -21.2369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9702 -21.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7836 -22.0703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2652 -21.4048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9317 -20.6611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6770 -15.4586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6758 -14.6414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3853 -15.8661 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3830 -14.2341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3821 -13.4177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6732 -13.0094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.9638 -13.4234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9682 -14.2385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 1 0
4 6 1 0
6 7 2 0
7 8 1 0
1 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
8 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.37 | Molecular Weight (Monoisotopic): 324.0681 | AlogP: 2.98 | #Rotatable Bonds: 5 |
Polar Surface Area: 80.38 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.86 | CX Basic pKa: 3.10 | CX LogP: 2.46 | CX LogD: 2.46 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.58 | Np Likeness Score: -1.98 |
References
1. (2012) Inhibitors of eya2, |